DLDRX
Price
$46.01
Change
-$0.09 (-0.20%)
Updated
Sep 17 closing price
Net Assets
992.53M
PRNEX
Price
$42.21
Change
-$0.06 (-0.14%)
Updated
Sep 17 closing price
Net Assets
2.43B
Interact to see
Advertisement

DLDRX vs PRNEX

Header iconDLDRX vs PRNEX Comparison
Open Charts DLDRX vs PRNEXBanner chart's image
BNY Mellon Natural Resources I
Price$46.01
Change-$0.09 (-0.20%)
VolumeN/A
Net Assets992.53M
T. Rowe Price New Era
Price$42.21
Change-$0.06 (-0.14%)
VolumeN/A
Net Assets2.43B
DLDRX vs PRNEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLDRX vs. PRNEX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLDRX is a Buy and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.43B vs. DLDRX (993M). PRNEX pays higher dividends than DLDRX: PRNEX (1.86) vs DLDRX (1.37). DLDRX was incepted earlier than PRNEX: DLDRX (22 years) vs PRNEX (57 years). DLDRX (0.89) is less costly to investors than PRNEX (0.77). DLDRX is a more actively managed with annual turnover of: 103.94 vs. PRNEX (24.30). DLDRX has a lower initial minimum investment than PRNEX: DLDRX (1000) vs PRNEX (2500). PRNEX annual gain was more profitable for investors over the last year : 8.15 vs. DLDRX (-3.13). DLDRX return over 5 years is better than : 72.66 vs. PRNEX (63.01).
DLDRXPRNEXDLDRX / PRNEX
Total Expense Ratio0.890.77116%
Annual Report Gross Expense Ratio0.890.77116%
Fund Existence22 years57 years-
Gain YTD5.37113.75139%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets993M2.43B41%
Annual Yield % from dividends1.371.8674%
Returns for 1 year-3.138.15-38%
Returns for 3 years-11.9415.96-75%
Returns for 5 years72.6663.01115%
Returns for 10 years88.9174.22120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCNSX19.20N/A
N/A
Fidelity Series Canada
ARIFX12.93N/A
N/A
Aristotle International Eq I
AGRCX11.41N/A
N/A
AB Growth C
LMCKX9.26N/A
N/A
Miller Income FI
GEMPX14.35N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn P